期刊文献+

半枝莲提取物逆转上皮间质转化抑制肝癌细胞迁移侵袭研究 被引量:21

Study on Inhibition of Reversal of Epithelial-mesenchymal Transition by Extracts from Scutellaria Barbata for Cell Migration and Invasion of Hepatoma Cells
下载PDF
导出
摘要 目的:探讨半枝莲提取物(Extracts from Scutellaria barbata,ESB)对肝癌HepG2细胞迁移、侵袭的抑制作用及分子机制。方法:利用转化生长因子-β(Transforming growth factor-β,TGF-β)诱导肝癌HepG2细胞上皮间质转化模型,通过MTT法、Transwell实验测定细胞增殖、迁移及侵袭能力,Western blot检测各组细胞相关蛋白表达情况。结果:MTT结果显示ESB抑制HepG2细胞增殖,且呈浓度及时间依赖性,24 h及48 h IC50分别为317.3μg/mL,243.8μg/mL。Transwell实验显示,与对照组比较,TGF-β组细胞迁移与侵袭能力增强(P <0.05);与TGF-β组比较,TGF-β+5μg/mL ESB组,TGF-β+10μg/mL ESB组细胞迁移及侵袭能力减弱(P <0.05)。Western blot实验显示,在建立上皮间质转化模型后,与TGF-β组比较,TGF-β+ESB (5μg/mL、10μg/mL)组E钙黏蛋白(E-cadherin)表达上调(P <0.05),N钙黏蛋白(N-cadherin)和波形蛋白(Vimentin)表达下调(P <0.05),同时磷酸化的Smad2蛋白(Phosphorylated Smad2,p-Smad2)、磷酸化的Smad3蛋白(Phosphorylated Smad3,p-Smad3)、磷酸化的c-Jun氨基末端激酶(Phosphorylated c-Jun N-terminal kinase,p-JNk)、磷酸化的p38蛋白(Phosphorylated p-38,pp38)、磷酸化的胞外信号调节激酶(Phosphorylated extracellular regulated protein kinases,p-ERK)、整合素αV亚单位(IntegrinαV)、整合素β3亚单位(Integrinβ3)、基质金属蛋白酶2 (matrix metalloprotein2, MMP2)、基质金属蛋白酶9 (matrix metalloprotein9,MMP9)表达显著下调(P <0.05)。结论:ESB可能通过阻断TGF-β/Smad/AMPK信号通路,下调IntegrinαV、Integrinβ3、MMP2及MMP9逆转TGF-β诱导的上皮间质转化,抑制肝癌HepG2细胞迁移及侵袭。 Objective:To investigate the inhibitory effect and molecular mechanism of extracts from Scutellaria barbata(ESB)on cell migration and invasion of hepatoma cell HepG2.Methods:Used transforming growth factor-β(TGF-β)to induce transformation model of epithelial-mesenchymal transition in hepatoma cell HepG2.Measured cell proliferation,migration and invasion by MTT assay and Transwell experiment,and detected the expression of related proteins in each group by applying Western blot.Results:Results of MTT assay showed that ESB inhibited HepG2 cell proliferation in a concentration-and time-dependent manner,with IC50 of 317.3μg/mL and 243.8μg/mL at 24 h and 48 h,respectively.Transwell experiments showed that compared with the control group,the cell proliferation and migration were increase in the TGF-βgroup(P<0.05),Compared with the TGF-βgroup,the cell proliferation and migration were reduced in the group of TGF-β+5μg/mL ESB and the group of TGF-β+10μg/mL ESB(P<0.05).Western blot analysis showed that after establishing the epithelialmesenchymal transformation models,compared with the TGF-βgroup,the E-cadherin expression was up-regulated in the group of TGF-β+ESB(5μg/mL,10μg/mL)(P<0.05);N-cadherin and vimentin expressions were down-regulated(P<0.05);at the same time,the expressions of phosphorylated Smad2 protein(p-Smad2),phosphorylated Smad3 protein(p-Smad3),phosphorylated c-Jun N-terminal kinase(p-JNk),phosphorylated p-38 protein(p-p38),phosphorylated extracellular signal-regulated kinase(p-ERK),integrinαV unit,integrinβ3 subunit,matrix metalloproteinase 2(MMP2)and matrix metalloproteinase-9(MMP9)were significantly down-regulated(P<0.05).Conclusion:ESB may block TGF-β/Smad/AMPK signaling pathway,down-regulate the reversal of epithelial-mesenchymal transformation of IntegrinαV,Integrinβ3,MMP2 and MMP9,and inhibit cell migration and invasion of hepatoma cell HepG2.
作者 黄有星 张生 刘开睿 HUANG Youxing;ZHANG Sheng;LIU Kairui
出处 《新中医》 CAS 2019年第8期17-21,共5页 New Chinese Medicine
基金 广东省科技厅科技计划项目(2017KT1718)
关键词 肝癌 半枝莲提取物(ESB) 转化生长因子-β(TGF-β) 细胞实验 Liver cancer Extract of Scutellariae barbatae(ESB) Transforming growth factor-β(TGF-β) Cell experiment
  • 相关文献

参考文献4

二级参考文献110

  • 1Nobuhisa Akamatsu,Yasuhiko Sugawara,Norihiro Kokudo.Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(9):626-631. 被引量:14
  • 2Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26:3291-3310.
  • 3Lee JC, Kumar S, Griswold DE, Underwood DC, Votta B J, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000; 47:185-201.
  • 4Hirosumi J, Tuncman'G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420:333-336.
  • 5Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74:49-139.
  • 6Raman M, Chen W, Cobb MH. Differential regulation of MAPKs. Oncogene 2007; 26:3100-3112.
  • 7Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001 ; 81:807-869.
  • 8Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911-1912.
  • 9Yoon S, Seger R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24:21-44.
  • 10Gille H, Kortenjann M, Thomae O, et al. ERK phosphorylation potentiates Elk- 1-mediated ternary complex formation and transactivation. EMBO J 1995; 14:951-962.

共引文献188

同被引文献389

引证文献21

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部